Seagen Inc., a biotechnology company that develops treatments for cancer and is about to embark on an ambitious expansion plan abroad, is growing in its home turf of Washington after striking a build-to-suit deal with developer Dermody Properties.
Seagen Inc., a biotechnology company that develops treatments for cancer and is about to embark on an ambitious expansion plan abroad, is growing in its home turf of Washington after striking a build-to-suit deal with developer Dermody Properties.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In